Legato Capital Management’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $29K | Sell |
16,859
-221
| -1% | -$380 | ﹤0.01% | 560 |
|
|
2025
Q1 | $56.9K | Sell |
17,080
-1,138
| -6% | -$3.79K | 0.01% | 540 |
|
|
2024
Q4 | $135K | Hold |
18,218
| – | – | 0.02% | 530 |
|
|
2024
Q3 | $171K | Hold |
18,218
| – | – | 0.02% | 528 |
|
|
2024
Q2 | $146K | Buy |
18,218
+131
| +0.7% | +$1.05K | 0.02% | 528 |
|
|
2024
Q1 | $268K | Hold |
18,087
| – | – | 0.03% | 515 |
|
|
2023
Q4 | $147K | Buy |
18,087
+642
| +4% | +$5.22K | 0.02% | 540 |
|
|
2023
Q3 | $79.4K | Buy |
+17,445
| New | +$79.4K | 0.01% | 534 |
|